{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T07:46:55Z","timestamp":1793951215663,"version":"4.8.0"},"reference-count":33,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"unspecified","delay-in-days":18,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,3,7]]},"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>We aimed to characterise the association between inflammatory bowel disease (IBD) and IBD medications and risk of cardiac arrhythmia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, setting and participants<\/jats:title>\n                    <jats:p>In a retrospective population-based study using the University of Manitoba IBD Epidemiology Database (Manitoba, Canada) from 1984 to 2018, we identified 10 992 IBD cases and 102 875 matched controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Analysis<\/jats:title>\n                    <jats:p>Arrhythmia risk in IBD was adjusted for the presence of comorbidities of the Charlson Comorbidity Index. The effect of IBD medications on the development of arrhythmia was assessed in a nested cohort study of individuals with IBD. Cases were censored at the date of first database identification of a diagnosis of heart failure or myocardial infarction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The cohort was 48.5% Crohn\u2019s disease and 51.5% ulcerative colitis, and 80.5% were incident cases. The median age of incident cases at IBD diagnosis was 35 (IQR, 25 to 49). The median age at arrhythmia diagnosis for persons with IBD was 69 years (IQR, 59 to 77) and for controls 69 years (IQR, 59 to 78). Persons diagnosed with IBD were more likely than controls (HR 1.51; 95% CI, 1.30 to 1.76) to develop arrhythmia. Persons within their sixth decade or younger had increased risk of arrhythmia. When controlling for comorbidities, the significant association between IBD and arrhythmia remains. Medications including 5-aminosalicylates, thiopurines and tumour necrosis factor-\u03b1 inhibitors were not associated with arrhythmia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Persons with IBD have a higher risk of arrhythmia prior to a diagnosis with heart disease. Use of IBD medications was not associated with risk of arrhythmia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-097687","type":"journal-article","created":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T23:42:37Z","timestamp":1742773357000},"page":"e097687","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Cardiac arrhythmia in patients with inflammatory bowel disease: a retrospective, population-based cohort study in Manitoba, Canada"],"prefix":"10.1136","volume":"15","author":[{"given":"Mariam","family":"Narous","sequence":"first","affiliation":[{"name":"University of Manitoba Faculty of Health Sciences, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoann","family":"Nugent","sequence":"additional","affiliation":[{"name":"University of Manitoba Faculty of Health Sciences, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inna","family":"Rabinovich-Nikitin","sequence":"additional","affiliation":[{"name":"University of Manitoba Faculty of Health Sciences, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorrie","family":"Kirshenbaum","sequence":"additional","affiliation":[{"name":"University of Manitoba Faculty of Health Sciences, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8041-3574","authenticated-orcid":false,"given":"Charles N","family":"Bernstein","sequence":"additional","affiliation":[{"name":"University of Manitoba Faculty of Health Sciences, Winnipeg, Manitoba, Canada"},{"name":"Gastroenterology, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,3,21]]},"reference":[{"key":"2025121513284791000_15.3.e097687.1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1615600"},{"key":"2025121513284791000_15.3.e097687.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2007.09.016"},{"key":"2025121513284791000_15.3.e097687.3","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1007\/s00431-024-05468-9","article-title":"Risk of atrial fibrillation development in adolescent patients with inflammatory bowel disease","volume":"183","author":"El Amrousy","year":"2024","journal-title":"Eur J Pediatr"},{"key":"2025121513284791000_15.3.e097687.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2019.10.001"},{"key":"2025121513284791000_15.3.e097687.5","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-021-00492-8"},{"key":"2025121513284791000_15.3.e097687.6","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1177\/2047487318792952","article-title":"Inflammatory bowel disease and cardiovascular disease incidence and mortality: A meta-analysis","volume":"25","author":"Sun","year":"2018","journal-title":"Eur J Prev Cardiol"},{"key":"2025121513284791000_15.3.e097687.7","first-page":"RA225","article-title":"Atrial fibrillation and electrical remodeling: the potential role of inflammation and oxidative stress","volume":"9","author":"Korantzopoulos","year":"2003","journal-title":"Med Sci Monit"},{"key":"2025121513284791000_15.3.e097687.8","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/echo.13261","article-title":"Atrial Electromechanical Properties in Inflammatory Bowel Disease","volume":"33","author":"Efe","year":"2016","journal-title":"Echocardiography"},{"key":"2025121513284791000_15.3.e097687.9","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ejim.2020.02.029","article-title":"Atrial fibrillation in patients with inflammatory bowel disease: A systematic review and meta-analysis","volume":"76","author":"Zuin","year":"2020","journal-title":"Eur J Intern Med"},{"key":"2025121513284791000_15.3.e097687.10","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000002562"},{"key":"2025121513284791000_15.3.e097687.11","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eut312"},{"key":"2025121513284791000_15.3.e097687.12","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/ibd\/izaa258","article-title":"Cardiovascular Risk Assessment and Impact of Medications on Cardiovascular Disease in Inflammatory Bowel Disease","volume":"27","author":"Sinh","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"2025121513284791000_15.3.e097687.13","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-007-0328-y"},{"key":"2025121513284791000_15.3.e097687.14","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.07.039"},{"key":"2025121513284791000_15.3.e097687.15","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1007\/BF03403825","article-title":"Learning from the census: the Socio-economic Factor Index (SEFI) and health outcomes in Manitoba","volume":"103","author":"Chateau","year":"2012","journal-title":"Can J Public Health"},{"key":"2025121513284791000_15.3.e097687.16","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009735"},{"key":"2025121513284791000_15.3.e097687.17","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.3748\/wjg.v25.i22.2788","article-title":"Increased risk of atrial fibrillation in patients with inflammatory bowel disease: A nationwide population-based study","volume":"25","author":"Choi","year":"2019","journal-title":"World J Gastroenterol"},{"key":"2025121513284791000_15.3.e097687.18","doi-asserted-by":"publisher","DOI":"10.4103\/1319-3767.166208"},{"key":"2025121513284791000_15.3.e097687.19","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4103\/sjg.sjg_622_20","article-title":"Is there any link between atrial arrhythmias and inflammatory bowel disease?","volume":"27","author":"Can","year":"2021","journal-title":"Saudi J Gastroenterol"},{"key":"2025121513284791000_15.3.e097687.20","doi-asserted-by":"crossref","DOI":"10.1177\/1179546820955179","article-title":"An Investigation into the Association Between Inflammatory Bowel Disease and Cardiac Arrhythmias: An Examination of the United States National Inpatient Sample Database","volume":"14","author":"Mubasher","year":"2020","journal-title":"Clin Med Insights Cardiol"},{"key":"2025121513284791000_15.3.e097687.21","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.5114\/amsad.2021.105256","article-title":"Association of atrial fibrillation with outcomes in patients hospitalized with inflammatory bowel disease: an analysis of the National Inpatient Sample","volume":"6","author":"Rahman","year":"2021","journal-title":"Arch Med Sci Atheroscler Dis"},{"key":"2025121513284791000_15.3.e097687.22","first-page":"673","article-title":"Impact of atrial fibrillation on inflammatory bowel disease hospitalizations-a nationwide retrospective study","volume":"34","author":"Kichloo","year":"2021","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"2025121513284791000_15.3.e097687.23","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/1744666X.2023.2174971","article-title":"The oft-overlooked cardiovascular complications of inflammatory bowel disease","volume":"19","author":"Massironi","year":"2023","journal-title":"Expert Rev Clin Immunol"},{"key":"2025121513284791000_15.3.e097687.24","doi-asserted-by":"crossref","DOI":"10.1038\/s44325-024-00026-6","article-title":"Recent advances in understanding the roles of T cells in atrial fibrillation","volume":"1","author":"Pu","year":"2024","journal-title":"npj Cardiovasc Health"},{"key":"2025121513284791000_15.3.e097687.25","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.3748\/wjg.v30.i15.2068","article-title":"Combination treatment of inflammatory bowel disease: Present status and future perspectives","volume":"30","author":"Triantafillidis","year":"2024","journal-title":"World J Gastroenterol"},{"key":"2025121513284791000_15.3.e097687.26","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.812631","article-title":"Effect of Anti-Rheumatic Drugs on Cardiovascular Disease Events in Rheumatoid Arthritis","volume":"8","author":"Baoqi","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"2025121513284791000_15.3.e097687.27","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s12026-016-8833-7","article-title":"Biologic drugs and arrhythmic risk in chronic inflammatory arthritis: the good and the bad","volume":"65","author":"Lazzerini","year":"2017","journal-title":"Immunol Res"},{"key":"2025121513284791000_15.3.e097687.28","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-303285"},{"key":"2025121513284791000_15.3.e097687.29","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4212\/cjhp.v69i6.1610","article-title":"5-Aminosalicylic Acid-Associated Myocarditis and Pericarditis: A Narrative Review","volume":"69","author":"Brown","year":"2016","journal-title":"Can J Hosp Pharm"},{"key":"2025121513284791000_15.3.e097687.30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139745","article-title":"Risk of Ischaemic Heart Disease in Patients with Inflammatory Bowel Disease: Cohort Study Using the General Practice Research Database","volume":"10","author":"Close","year":"2015","journal-title":"PLoS One"},{"key":"2025121513284791000_15.3.e097687.31","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/MCG.0000000000000408","article-title":"Antitumor Necrosis Factor-\u03b1 Therapy Is Associated With Reduced Risk of Thromboembolic Events in Hospitalized Patients With Inflammatory Bowel Disease","volume":"50","author":"deFonseka","year":"2016","journal-title":"J Clin Gastroenterol"},{"key":"2025121513284791000_15.3.e097687.32","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/ajg.2017.479","article-title":"Increased Mortality Rates With Prolonged Corticosteroid Therapy When Compared With Antitumor Necrosis Factor-\u03b1-Directed Therapy for Inflammatory Bowel Disease","volume":"113","author":"Lewis","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"2025121513284791000_15.3.e097687.33","doi-asserted-by":"publisher","DOI":"10.1177\/039463201102400131"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-097687","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T21:28:55Z","timestamp":1765834135000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-097687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3,21]]},"published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.1136\/bmjopen-2024-097687"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-097687","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3]]}}}